If you need more lookups,
subscriptions start at $34 USD/month.
Scott Ezell Location
California, United States
Scott Ezell Work
2023 -now Senior Director, Clinical Research @
2021 -2023 Director, Translational Medicine @
2020 -2021 Principal Data Scientist @
2018 -2020 Principal Scientist @
2016 -2018 Biological data scientist @
2015 -2016 Lead Biologist @
2015 -2015 Lead Biologist @
Scott Ezell Education
Harvard Medical School - Massachusetts General Hospital
Postdoctoral Research Fellow (Molecular Biology)
2012-2013
Tufts University
Doctor of Philosophy (Ph.D.) (Biochemistry)
2006-2012
University of Bristol
BSc (Biochemistry)
2003-2006
Scott Ezell Skills
Data Analytics
Drug Discovery
Python
Molecular Biology
Biochemistry
Data Visualization
Bioinformatics
Genomics
Cell Biology
Shell Scripting
Object-Oriented Programming (OOP)
Machine Learning
R
SQL
NoSQL
Natural Language Processing
Cell Signaling
Signal Transduction
Cancer Research
Scientific Writing
Amazon Web Services (AWS)
Artificial Neural Networks
Electronic Medical Record (EMR)
NGS
Linux
Biostatistics
Plotly
Bioconductor
Deep Learning
Neural Networks
Data Mining
Unstructured Data
Computational Biology
Biopython
DNA Sequencing
TensorFlow
Keras
NumPy
Western Blotting
Cell Culture
Transfection
Molecular Cloning
qPCR
Protein Expression
ELISA
Tissue Culture
Protein Purification
RT-PCR
Immunofluorescence
Mouse tumor models
Real-Time Polymerase Chain Reaction (qPCR)
Small Molecules
Differential
Regulatory Risk
ERD
Flask
Business Process Analysis
Workflow
Pharmaceutics
Programming
Research
Restful Web Services
Amazon S3
Regulatory Compliance
Congress
Proteomics
Rxnorm
Cell
MongoDB
Oncology
Site Directed
Analysis
FDA
Streamline
Modifying
Evidence
Rt Pcr
Health Consulting
Internet Explorer
Business Insights
Pathogens
Pharmaceutical Industry
Mergers and Acquisitions
Computing
Medical Records
Boston
Business Case
Software Implementation
Amazon Web Services Aws
Data Science
Renewal
Cros
Life Sciences
Sensitivity
Management
Onyx
Prescription
Biotechnology
Clinical Research
Pharmacology
Amazon EC2
Concord
Technical Writing
Cross Functional Team Leadership
Applications
Business Process
OOP
Access Control
Version Control
Lymphoma
Microsoft Excel
Article
DMPK
Abstracts
Strategy
Pipelines
Umls
North America
ARM
SciPy
International
Kinase Assays
Scientific
Signalling
Resistance
Strategic Planning
Natural Language
Combination
Project Planning
Canning
Regulations
Switching
Disease
Drug Resistance
Molecular
Axis
Apoptosis
Strategies
RNAi
Agile Methodologies
Programming Languages
Lung
Breast Cancer
Wang
Induction
Mutagenesis
Chemistry
Decision Making
Customer Service
Internal Controls
Partnerships
Asia
Stem Cells
Reports
HIPAA
Design
Parkinson's
Extract
Science
Phosphorylation
Data Analysis
Pharmacovigilance
Abc
Diffuse
MedDRA
PowerPoint
Hospitals
Technical Requirements
Real Time Polymerase Chain Reaction Qpcr
Immunoprecipitation
Drug Development
Site Directed Mutagenesis
Object Oriented Programming Oop
Project Plans
Shell
Biology
Population Health
Data Driven Testing
Clinical Trials
Europe
Author
SaaS
Visualization
Immunology
Breast
Biomarkers
Therapists
Validation
Consulting
IBM
RNA
Reuse
Software Solutions
Res
Healthcare
Predictive Analytics
Linking
C
Infection
Cancer
Icd 10
Medicine
Transcription
Unit Testing
Scholarships
Usa
NLTK
Watson
Text Editing
Publications
Electronic Medical Record Emr
Amazon Web Services
Object Oriented Programming
Electronic Medical Record
Scott Ezell Summary
Scott Ezell, based in California, United States, is currently a Senior Director, Clinical Research at Nuvation Bio. Scott Ezell brings experience from previous roles at Nuvation Bio, ConcertAI, Valo and IBM Watson Health. Scott Ezell holds a 2012 - 2013 Postdoctoral Research Fellow in Molecular Biology @ Harvard Medical School - Massachusetts General Hospital. With a robust skill set that includes Data Analytics, Drug Discovery, Python, Molecular Biology, Biochemistry and more. Scott Ezell has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Scott Ezell?
Find contact details for 700 million professionals.